Genmab (GMAB) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Genmab A/S, a Copenhagen-based company, has authorized its Board of Directors to increase the share capital by up to DKK 6,600,000 and issue warrants for employees, excluding executives, until 2029. The company is also permitted to issue convertible debt instruments, allowing for a potential further increase in share capital. These strategic financial maneuvers are designed to support Genmab’s ongoing medical research and business operations.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
